0
AutoLumo CLIA Infectious Disease Markers, 100 Tests
Catalog No :
CAS Number :
Brand :
In Stock
Specifications:
| Application | Chemiluminescent Immunoassay |
| Storage Temperature | 2-8°C |
| Product Type | CLIA Reagent |
| Product Brand | Autobio Diagnostics |
| Product Grade | Medical grade |
The AutoLumo CLIA Infectious Disease Marker Microparticles are advanced chemiluminescent immunoassay (CLIA) reagents designed for quantitative and qualitative detection of infectious disease markers in human serum or plasma.
Each reagent kit contains magnetic microparticle-based immunoreagents coated with highly specific antibodies or antigens for sensitive and accurate detection.
Compatible with AutoLumo CLIA Analyzers, these reagents deliver rapid, reproducible, and reliable diagnostic results for infectious diseases, including hepatitis, HIV, syphilis, tuberculosis, TORCH infections, and SARS-CoV-2.
The reagents are manufactured under CE-certified quality standards (selected models) and optimized for clinical diagnostic laboratories, blood banks, and public health screening programs.
Key Features
- High Sensitivity and Specificity: Magnetic microparticle technology ensures precise antigen–antibody binding.
- Comprehensive Infectious Disease Coverage: Includes hepatitis, HIV, TP, TORCH, TB, and SARS-CoV-2 panels.
- Automation-Ready Format: Designed for seamless integration with AutoLumo CLIA Analyzers.
- Quantitative and Qualitative Detection: Supports diverse testing requirements.
- CE Marked Kits Available: Validated for clinical use in compliant markets.
- Consistent and Reproducible Results: Stable formulation minimizes variation between batches.
- Wide Clinical Application: Suitable for screening, diagnosis, and monitoring of infectious diseases.
Product Range
Hepatitis B Panel
| Code | Marker | Description | Pack Size | CE Mark |
|---|---|---|---|---|
| CMC0102 | HBsAg | Hepatitis B Surface Antigen CLIA Microparticles | 100 Tests | Yes |
| CMC0202 | Anti-HBs | Antibody to Hepatitis B Surface Antigen | 100 Tests | Yes |
| CMC0302 | HBeAg | Hepatitis B e Antigen CLIA Microparticles | 100 Tests | - |
| CMC0402 | Anti-HBe | Antibody to Hepatitis B e Antigen | 100 Tests | - |
| CMC0407 | Anti-HBe II | Second-generation Anti-HBe CLIA Microparticles | 100 Tests (S) | - |
| CMC0502 | Anti-HBc | Antibody to Hepatitis B Core Antigen | 100 Tests | - |
| CMC0802 | HBV PreS1-Ag | Hepatitis B PreS1 Antigen CLIA Microparticles | 100 Tests | - |
| CMC0902 | Anti-HBc IgM | IgM Antibody to Hepatitis B Core Antigen | 100 Tests | - |
| CMC1202 | HBsAg II | Hepatitis B Surface Antigen CLIA Microparticles II | 100 Tests | No |
| CMC1207 | HBsAg II (S) | Hepatitis B Surface Antigen CLIA Microparticles II (Special) | 100 Tests | No |
Other Infectious Diseases
| Code | Marker | Description | Pack Size | CE Mark |
|---|---|---|---|---|
| CMC0602 | Anti-HCV IgG | Hepatitis C Virus Antibody CLIA Microparticles | 100 Tests | Yes |
| CMC0702 | Anti-HAV IgM | Hepatitis A Virus IgM Antibody CLIA Microparticles | 100 Tests | Yes |
| CMC1002 | HEV IgM | Hepatitis E Virus IgM Antibody CLIA Microparticles | 100 Tests | Yes |
| CMC1102 | HEV IgG | Hepatitis E Virus IgG Antibody CLIA Microparticles | 100 Tests | Yes |
| CMJ0102 | Anti-HIV | HIV Antibody CLIA Microparticles | 100 Tests | - |
| CMJ0103 | HIV Ag/Ab Combo | HIV Antigen/Antibody Combination Assay | 100 Tests | - |
| CMJ0202 | Anti-TP | Treponema pallidum Antibody CLIA Microparticles (Syphilis) | 100 Tests | Yes |
| CMT0102 | TB T-Cell Immunity | Mycobacterium tuberculosis T-cell Immunity CLIA Microparticles | 28 Tests | Yes |
| CMV0102 | HP IgG | Helicobacter pylori IgG CLIA Microparticles | 100 Tests | No |
TORCH Panel
| Code | Marker | Description | Pack Size | CE Mark |
|---|---|---|---|---|
| CMK0102 | Toxo IgM | Toxoplasma gondii IgM CLIA Microparticles | 100 Tests | Yes |
| CMK0202 | CMV IgM | Cytomegalovirus IgM CLIA Microparticles | 100 Tests | Yes |
| CMK0302 | Rubella IgM | Rubella Virus IgM CLIA Microparticles | 100 Tests | Yes |
| CMK0402 | HSV-1 IgM | Herpes Simplex Virus Type 1 IgM CLIA Microparticles | 100 Tests | Yes |
| CMK0502 | HSV-2 IgM | Herpes Simplex Virus Type 2 IgM CLIA Microparticles | 100 Tests | Yes |
| CMK0602 | Toxo IgG | Toxoplasma gondii IgG CLIA Microparticles | 100 Tests | Yes |
| CMK0702 | CMV IgG | Cytomegalovirus IgG CLIA Microparticles | 100 Tests | Yes |
| CMK0802 | Rubella IgG | Rubella Virus IgG CLIA Microparticles | 100 Tests | Yes |
| CMK0902 | HSV-1 IgG | Herpes Simplex Virus Type 1 IgG CLIA Microparticles | 100 Tests | Yes |
| CMK1002 | HSV-2 IgG | Herpes Simplex Virus Type 2 IgG CLIA Microparticles | 100 Tests | Yes |
COVID-19 Panel
| Code | Marker | Description | Pack Size | CE Mark |
|---|---|---|---|---|
| CMU0302 | SARS-CoV-2 IgG II | SARS-CoV-2 IgG Antibody CLIA Microparticles | 100 Tests | Yes |
| CMU0402 | SARS-CoV-2 IgM II | SARS-CoV-2 IgM Antibody CLIA Microparticles | 100 Tests | Yes |
| CMU0502 | SARS-CoV-2 RBD Ab | SARS-CoV-2 Receptor Binding Domain Antibody CLIA Microparticles | 100 Tests | Yes |
| CMU0702 | SARS-CoV-2 Nab Q | SARS-CoV-2 Neutralizing Antibody Quantitative CLIA Microparticles | 100 Tests | Yes |
Clinical Applications
- Hepatitis Screening & Diagnosis: HBV, HCV, HAV, and HEV marker detection.
- HIV & STD Screening: HIV, Syphilis (TP), and other sexually transmitted infection diagnostics.
- Tuberculosis (TB) Immunity Testing: Detection of T-cell response against Mycobacterium tuberculosis.
- TORCH Panel Screening: Detection of maternal infections (Toxoplasma, Rubella, CMV, HSV) during pregnancy.
- COVID-19 Antibody Testing: Quantitative and qualitative SARS-CoV-2 IgG, IgM, and neutralizing antibody analysis.
- General Infectious Disease Monitoring: Comprehensive infection screening for clinical and public health laboratories.
Performance Characteristics
- Detection Method: Chemiluminescent Immunoassay (CLIA)
- Technology: Magnetic microparticle-based sandwich immunoassay
- Precision: Coefficient of Variation (CV) ≤ 10%
- Sample Type: Human serum or plasma
- Storage Conditions: 2–8°C, protected from light
- Shelf Life: 12 months from manufacturing date
Unique Advantages
- Broad infectious disease coverage in a single reagent platform.
- Magnetic microparticle technology ensures rapid, reliable results.
- CE-marked kits available for regulated diagnostic use.
- Stable formulations optimized for AutoLumo CLIA systems.
- Suitable for high-throughput laboratories and reference centers.
The AutoLumo CLIA Infectious Disease Marker Microparticles provides a comprehensive range of CLIA reagents for the detection of key infectious disease biomarkers.
With high sensitivity, precision, and reproducibility, these reagents support routine diagnostic testing, blood screening, and epidemiological surveillance.
Ideal for hospitals, clinical laboratories, blood banks, and research centers, the AutoLumo CLIA infectious disease panel ensures accurate and dependable diagnostic performance across multiple infectious agents.
- Target Marker: Hepatitis B Surface Antigen (HBsAg) Antibody to Hepatitis B Surface Antigen (Anti-HBs) Hepatitis B e Antigen (HBeAg) Antibody to Hepatitis B e Antigen (Anti-HBe) Second-generation Anti-HBe (Anti-HBe II) Antibody to Hepatitis B Core Antigen (Anti-HBc) Hepatitis B PreS1 Antigen (HBV PreS1-Ag ) IgM Antibody to Hepatitis B Core Antigen (Anti-HBc IgM) Hepatitis B Surface Antigen (HBsAg II) Hepatitis C Virus Antibody (Anti-HCV IgG) Hepatitis A Virus IgM Antibody (Anti-HAV IgM) Hepatitis E Virus IgM Antibody (HEV IgM) Hepatitis E Virus IgG Antibody (HEV IgG) HIV Antibody (Anti-HIV ) HIV Antigen/Antibody Combination Assay (HIV Ag/Ab Combo) Treponema pallidum Antibody (Syphilis) - Anti-TP Mycobacterium tuberculosis T-cell Immunity (TB T-Cell Immunity)** 28 Tests Pack Helicobacter pylori IgG (HP IgG) Toxoplasma gondii IgM (Toxo IgM) Cytomegalovirus IgM (CMV IgM) Rubella Virus IgM Herpes Simplex Virus Type 1 IgM (HSV-1 IgM) Herpes Simplex Virus Type 2 IgM (HSV-2 IgM) Toxoplasma gondii IgG Cytomegalovirus IgG (CMV IgG ) Rubella Virus IgG Herpes Simplex Virus Type 1 IgG (HSV-1 IgG) Herpes Simplex Virus Type 2 IgG (HSV-2 IgG) SARS-CoV-2 IgG Antibody (SARS-CoV-2 IgG II) SARS-CoV-2 IgM Antibody (SARS-CoV-2 IgM II) SARS-CoV-2 Receptor Binding Domain Antibody (SARS-CoV-2 RBD Ab) SARS-CoV-2 Neutralizing Antibody Quantitative (SARS-CoV-2 Nab Q)